Neoantigen Cancer Vaccine Market to Climb the Exponential Growth Curve | Forecast to 2031

by bis on Mar 7, 2022 Finance 489 Views

Neoantigen cancer vaccines are generally considered tumor-specific vaccines that are based on neoantigens being identified from an individual and further delivered via cell, protein, or nucleic acid-based platform with the utter aim of imparting a strong antitumor response. The neoantigen cancer vaccines are further segmented into personalized and off-the-shelf neovaccines based on the target neoantigen.

The global neoantigen cancer vaccine industry analysis by BIS Research projects the market to grow at a significant CAGR of 77.73% during the forecast period 2024-2031. The neoantigen cancer vaccine market is expected to generate $35.5 million in revenue in 2024, owing to the expected launch of the first neoantigen vaccine, DC vaccine in the market.

The neoantigen cancer vaccine market growth has been primarily attributed to major drivers in this market, such as rising prevalence of cancers, increasing adoption of personalized medicine to tailor patient’s treatment on an individual level, and significant external funding for executing research and development exercises. However, significant challenges are restraining the market growth. These challenges include the expected higher cost of personalized cancer vaccines, hurdles in clinical development, and payer uncertainty and outcome-based pricing.

The global neoantigen cancer vaccine market has been analyzed on the basis of segments mentioned in the following figure

blogpost.jpeg

Pipeline Segmentation

• The emerging neoantigen cancer vaccines are segmented based on product type into personalized and off-the-shelf neovaccines.
• The emerging neoantigen cancer vaccines are segmented based on disease/application into lung cancer, urinary system cancer, melanoma, liver cancer, head and neck cancer, and blood and bone marrow cancer.
• The emerging neoantigen cancer vaccines are segmented based on type of neovaccine into nucleic acid vaccine, peptide vaccine, and dendritic cell vaccine.
• The emerging neoantigen cancer vaccines are segmented based on line of therapy into first, second, and later lines therapy.
• The emerging neoantigen cancer vaccines are segmented based on development phase into Phase I, II, and III.
• The emerging neoantigen cancer vaccines are segmented on the basis of route-of-administration into intradermal, subcutaneous, and intramuscular administrations.

Expert Quote on the Neoantigen Cancer Vaccine Market

“The real issues with neovaccines are higher cost, turn-around times, and limited efficacy. The cost and time to manufacture have come down in the last four years, and as technology improves, it will come down more.”

The neoantigen cancer vaccine market report provides a holistic view of the market in terms of various factors influencing it, including reported clinical findings, financing and partnership opportunities, expected market, and current clinical landscape.

The scope of this report is centered upon conducting a detailed study of the products expected to be allied with the oncology market. In addition, the study also includes exhaustive information on the unmet needs, perception on the new products, competitive landscape, market share of key players, growth potential of each underlying sub segment and company, as well as other vital information with respect to the global neoantigen cancer vaccine market.

Market Growth Drivers
• Increasing Global Prevalence of Cancer

• Increase in Adoption of Personalized Medicine to Tailor Patient’s Treatment on an Individual Level

• Significant External Funding for Executing Research and Development Exercise

Market Challenges
• Higher Cost of Personalized Cancer Vaccines

• Hurdles in Clinical Development and Optimization Process

• Uncertain Reimbursement Scenario

• Payer Uncertainty and Outcome-Based Pricing

• High Capital Requirement Hampering the Expansion of Global Reach

Market Opportunities
• Treatment Gaps

• Reduced Turnaround Time and Cost

• Partnerships and Collaboration between Various Healthcare Stakeholders

• Data Analytics

Key Companies Profiled
Moderna Therapeutics, F. Hoffmann-La Roche Ltd, AstraZeneca plc, Agenus, OSE Immunotherapeutics, Advaxis, Medigene, Neon Therapeutics (Acquired by BioNTech SE), Genocea Biosciences, Immunovative Therapies, Gritstone Oncology, Nouscom, NantBioScience, Immunovaccine, BioLineRx, Geneos Therapeutics.

Key Questions Answered in this Report:

• What are the major market drivers, challenges, and opportunities in the global neoantigen cancer vaccines market?
• What are the underlying structures resulting in emerging trends within the global neoantigen cancer vaccines market?
• What key development strategies are implemented by the major players in order to sustain in the competitive market?
• What are the key regulatory implications in developed and developing regions for neoantigen cancer vaccines?
• How each segment of the market is expected to grow during the forecast period 2024-2031, and what is the estimated revenue to be generated by each of the segments on the basis of:
o Product Type (Personalized and Off-the-Shelf),
o Type of Neovaccine (Nucleic Acid Vaccine, Peptide Vaccine, and Dendritic Cell-Based Vaccine)
o Line of Therapy (First Line, Second Line, and Later Lines)
o Region, including North America, Europe, Asia-Pacific and Middle East
• Who are the leading players with significant offerings to the global neoantigen cancer vaccines market? What is the expected market dominance for each of these leading players?
• Which companies are anticipated to be highly disruptive in the future and why?
• What are the current treatment gaps, and how neovaccines are expected to fill these gaps?
• What are the unmet needs in the global neoantigen cancer vaccine market?

Request Sample - https://bisresearch.com/requestsample?id=1254type=download

The report scope exclusively covers biotechnology companies actively engaged in the development of Neoantigen Cancer Vaccine. The contract research and manufacturing organizations for neoantigen prediction, optimization, and vaccine manufacturing have not been considered as a part of the report. 

BIS Related Studies

Global Hematology Testing Market

Article source: https://article-realm.com/article/Finance/20056-Neoantigen-Cancer-Vaccine-Market-to-Climb-the-Exponential-Growth-Curve-Forecast-to-2031.html

Comments

No comments have been left here yet. Be the first who will do it.
Safety

captchaPlease input letters you see on the image.
Click on image to redraw.

Reviews

Guest

Overall Rating:

Most Viewed Articles

Statistics

Members
Members: 17299
Publishing
Articles: 80,086
Categories: 202
Online
Active Users: 1033
Members: 0
Guests: 1033
Bots: 4288
Visits last 24h (live): 7782
Visits last 24h (bots): 30053

Latest Comments

This news report covers a racial discrimination lawsuit and customer backlash against Walmart after shopper Essie Grundy and viral videos highlighted African-American hair and beauty products...
I really loved reading your blog. It was very well authored and easy to undertand. Unlike additional blogs I have read which are really not tht good. I also found your posts very interesting. In...
I appreciate the way this content avoids unnecessary fluff. It’s straightforward and to the point while still offering depth. That economy of words without sacrificing meaning is a true skill...
Very good points you wrote here..Great stuff...I think you've made some truly interesting points.Keep up the good work.  베트맨 도메인 주소    
Good to become visiting your weblog again, it has been months for me. Nicely this article that i've been waited for so long. I will need this post to total my assignment in the college, and it has...
What a fantabulous post this has been. Never seen this kind of useful post. I am grateful to you and expect more number of posts like these. Thank you very much. 판타스틱벳  
 I can’t believe focusing long enough to research; much less write this kind of article. You’ve outdone yourself with this material without a doubt. It is one of the greatest contents. 뽀빠이벳  
Wonderful blog! I found it while surfing around on Yahoo News. Do you have any suggestions on how to get listed in Yahoo News? I’ve been trying for a while but I never seem to get there!...
Very nice article. I enjoyed reading your post. very nice share. I want to twit this to my followers. Thanks !. 텐텐벳 주소  
Finding your account information is even easier shopping at Target! Sign in securely to Target Red Card Login to see your recent transactions, payments, and card activity.   
on Nov 14, 2026 about How To Succeed At Internet Marketing

Translate To: